MYOC Polyclonal Antibody

MYOC encodes the protein myocilin, which is believed to have a role in cytoskeletal function. MYOC is expressed in many occular tissues, including the trabecular meshwork, and was revealed to be the trabecular meshwork glucocorticoid-inducible response protein (TIGR). The trabecular meshwork is a specialized eye tissue essential in regulating intraocular pressure, and mutations in MYOC have been identified as the cause of hereditary juvenile-onset open-angle glaucoma.

Introducing the MYOC Polyclonal Antibody, a cutting-edge biotechnological solution designed to revolutionize the field of ophthalmology. This meticulously crafted antibody is specifically engineered to target and detect the myocilin protein, a key biomarker associated with glaucoma.

The MYOC Polyclonal Antibody boasts exceptional specificity and sensitivity, enabling accurate and reliable detection of myocilin in various biological samples. Its high affinity for the target protein ensures minimal cross-reactivity, guaranteeing precise and reproducible results.

Crafted with utmost precision, this antibody is produced through a rigorous process of immunization and purification, resulting in a highly purified and concentrated solution. Its superior quality and purity make it an ideal tool for a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA).

The MYOC Polyclonal Antibody is meticulously validated to meet the highest industry standards, ensuring optimal performance and consistency. Its exceptional stability and long shelf life make it a reliable and cost-effective choice for researchers and clinicians alike.

With its unparalleled performance and versatility, the MYOC Polyclonal Antibody is poised to revolutionize glaucoma research and diagnosis. Experience the power of precision and reliability with this groundbreaking biotechnological innovation.

Introducing the MYOC Polyclonal Antibody, a cutting-edge biotechnological solution designed to revolutionize the field of ophthalmology. This meticulously crafted antibody is specifically engineered to target and detect the myocilin protein, a key biomarker associated with glaucoma.

The MYOC Polyclonal Antibody boasts exceptional specificity and sensitivity, enabling accurate and reliable detection of myocilin in various biological samples. Its high affinity for the target protein ensures minimal cross-reactivity, guaranteeing precise and reproducible results.

Crafted with utmost precision, this antibody is produced through a rigorous process of immunization and purification, resulting in a highly purified and concentrated solution. Its superior quality and purity make it an ideal tool for a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA).

The MYOC Polyclonal Antibody is meticulously validated to meet the highest industry standards, ensuring optimal performance and consistency. Its exceptional stability and long shelf life make it a reliable and cost-effective choice for researchers and clinicians alike.

With its unparalleled performance and versatility, the MYOC Polyclonal Antibody is poised to revolutionize glaucoma research and diagnosis. Experience the power of precision and reliability with this groundbreaking biotechnological innovation.